| Lauren Amber Dankwa, APRN | |
|
700 Ne 13th St, Oklahoma City, OK 73104-5004 | |
| (405) 201-7047 | |
| Not Available |
| Full Name | Lauren Amber Dankwa |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 700 Ne 13th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518591122 | NPI | - | NPPES |
| 00000 | Other | I DONT HAVE THESE NUMBERS. |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | 116021 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Integris Canadian Valley Hospital | Yukon, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Hospital Medicine Associates Pc | 4880841618 | 18 |
| Oklahoma Hospital Medicine Physicians Llc | 9830510023 | 110 |
News Archive
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.
You were once a hollow shell. To sculpt that hollow ball into an organism with layers of internal organs, muscle and skin, portions of that embryonic 'shell' folded inwards. The same happens to fruit fly embryos, and researchers at the European Molecular Biology Laboratory in Heidelberg, Germany, have now identified a particular group of cells which are crucial for the first such fold.
Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 4 days ago
| Entity Name | Midwest Hospital Medicine Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124388855 PECOS PAC ID: 4880841618 Enrollment ID: O20120829000397 |
News Archive
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.
You were once a hollow shell. To sculpt that hollow ball into an organism with layers of internal organs, muscle and skin, portions of that embryonic 'shell' folded inwards. The same happens to fruit fly embryos, and researchers at the European Molecular Biology Laboratory in Heidelberg, Germany, have now identified a particular group of cells which are crucial for the first such fold.
Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 4 days ago
| Entity Name | Oklahoma Hospital Medicine Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871113761 PECOS PAC ID: 9830510023 Enrollment ID: O20200526000785 |
News Archive
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.
You were once a hollow shell. To sculpt that hollow ball into an organism with layers of internal organs, muscle and skin, portions of that embryonic 'shell' folded inwards. The same happens to fruit fly embryos, and researchers at the European Molecular Biology Laboratory in Heidelberg, Germany, have now identified a particular group of cells which are crucial for the first such fold.
Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 4 days ago
| Entity Name | Oklahoma Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417577305 PECOS PAC ID: 5597186940 Enrollment ID: O20200610003448 |
News Archive
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.
You were once a hollow shell. To sculpt that hollow ball into an organism with layers of internal organs, muscle and skin, portions of that embryonic 'shell' folded inwards. The same happens to fruit fly embryos, and researchers at the European Molecular Biology Laboratory in Heidelberg, Germany, have now identified a particular group of cells which are crucial for the first such fold.
Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Amber Dankwa, APRN 1433 Woodland Way, Oklahoma City, OK 73127-3259 Ph: (405) 201-7047 | Lauren Amber Dankwa, APRN 700 Ne 13th St, Oklahoma City, OK 73104-5004 Ph: (405) 201-7047 |
News Archive
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.
You were once a hollow shell. To sculpt that hollow ball into an organism with layers of internal organs, muscle and skin, portions of that embryonic 'shell' folded inwards. The same happens to fruit fly embryos, and researchers at the European Molecular Biology Laboratory in Heidelberg, Germany, have now identified a particular group of cells which are crucial for the first such fold.
Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 4 days ago
Jamie Louise Hunt, APRN-CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young, Andrews Academic Tower, Suite 8400, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 405-271-5892 | |
Mrs. Janet Elizabeth Kristic, APRN CLINICAL NURSE Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1117 Nw 50th, Oklahoma City, OK 73118 Phone: 405-842-4435 Fax: 405-842-2846 | |
Todd J Ramer, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 4300 W Memorial Rd, Oklahoma City, OK 73120 Phone: 405-752-3539 | |
Andrea Jeanne Mccoy, R.N. Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 4050 W Memorial Rd, Oklahoma City, OK 73120 Phone: 405-608-3800 Fax: 405-608-3838 | |
Shanelle Stensaas, APRN-CNS Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 3300 Nw Expressway, Oklahoma City, OK 73112 Phone: 405-613-3351 | |
Leighann Fullagar, APRN-CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3300 Nw Expressway, Oklahoma City, OK 73112 Phone: 405-713-7403 Fax: 405-713-2794 | |
Michelle Tull, ACNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 800 Ne 10th St, Oklahoma City, OK 73104 Phone: 405-271-3402 |